|
[1]
|
Katsura, C., Ogunmwonyi, I., Kankam, H.K. and Saha, S. (2022) Breast Cancer: Presentation, Investigation and Management. British Journal of Hospital Medicine, 83, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Barzaman, K., Karami, J., Zarei, Z., Hosseinzadeh, A., Kazemi, M.H., Moradi-Kalbolandi, S., et al. (2020) Breast Cancer: Biology, Biomarkers, and Treatments. International Immunopharmacology, 84, Article ID: 106535. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hendrick, R.E., Helvie, M.A. and Monticciolo, D.L. (2021) Breast Cancer Mortality Rates Have Stopped Declining in U.S. Women Younger than 40 Years. Radiology, 299, 143-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cejuela, M., Martin-Castillo, B., Menendez, J.A. and Pernas, S. (2022) Metformin and Breast Cancer: Where Are We Now? International Journal of Molecular Sciences, 23, Article No. 2705. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Mostafavi, S., Zalpoor, H. and Hassan, Z.M. (2022) The Promising Therapeutic Effects of Metformin on Metabolic Reprogramming of Cancer-Associated Fibroblasts in Solid Tumors. Cellular & Molecular Biology Letters, 27, Article No. 58. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chen, Y.C., Li, H. and Wang, J. (2020) Mechanisms of Metformin Inhibiting Cancer Invasion and Migration. American Journal of Translational Research, 12, 4885-4901.
|
|
[7]
|
Agius, L., Ford, B.E. and Chachra, S.S. (2020) The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective. International Journal of Molecular Sciences, 21, Article No. 3240. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Uprety, B. and Abrahamse, H. (2022) Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights. Cells, 11, Article No. 576. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Roshan, M.H., Shing, Y.K. and Pace, N.P. (2019) Metformin as an Adjuvant in Breast Cancer Treatment. SAGE Open Medicine, 7, 1-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Lohmann, A.E. and Goodwin, P.J. (2021) Diabetes, Metformin and Breast Cancer: A Tangled Web. Annals of Oncology, 32, 285-286. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chan, Y., Lin, R., Wang, Y., Hung, T., Huang, Y., Yu, J., et al. (2023) The Interplay between IGF-1R Signaling and Hippo-Yap in Breast Cancer Stem Cells. Cell Communication and Signaling, 21, Article No. 81. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Biello, F., Platini, F., D’Avanzo, F., Cattrini, C., Mennitto, A., Genestroni, S., et al. (2021) Insulin/Igf Axis in Breast Cancer: Clinical Evidence and Translational Insights. Biomolecules, 11, Article No. 125. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Gholami, M., Klashami, Z.N., Ebrahimi, P., Mahboobipour, A.A., Farid, A.S., Vahidi, A., et al. (2023) Metformin and Long Non-Coding RNAs in Breast Cancer. Journal of Translational Medicine, 21, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Yang, J., Zhou, Y., Xie, S., Wang, J., Li, Z., Chen, L., et al. (2021) Metformin Induces Ferroptosis by Inhibiting Ufmylation of SLC7A11 in Breast Cancer. Journal of Experimental & Clinical Cancer Research, 40, Article No. 206. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lee, H., Zandkarimi, F., Zhang, Y., Meena, J.K., Kim, J., Zhuang, L., et al. (2020) Energy-Stress-Mediated AMPK Activation Inhibits Ferroptosis. Nature Cell Biology, 22, 225-234. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Mostafavi, S. and Hassan, Z.M. (2024) The Anti-Neoplastic Effects of Metformin Modulate the Acquired Phenotype of Fibroblast Cells in the Breast Cancer-Normal Fibroblast Co-Culture System. Oncology Research, 32, 477-487. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Guo, Z., Zhang, H., Fu, Y., Kuang, J., Zhao, B., Zhang, L., et al. (2023) Cancer-Associated Fibroblasts Induce Growth and Radioresistance of Breast Cancer Cells through Paracrine IL-6. Cell Death Discovery, 9, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Barakat, H.E., Hussein, R.R.S., Elberry, A.A., Zaki, M.A. and Elsherbiny Ramadan, M. (2022) Factors Influencing the Anticancer Effects of Metformin on Breast Cancer Outcomes: A Systematic Review and Meta-Analysis. Expert Review of Anticancer Therapy, 22, 415-436. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Chikermane, S.G., Sharma, M., Abughosh, S.M., Aparasu, R.R., Trivedi, M.V. and Johnson, M.L. (2022) Dose-Dependent Relation between Metformin and the Risk of Hormone Receptor-Positive, Her2-Negative Breast Cancer among Postmenopausal Women with Type-2 Diabetes. Breast Cancer Research and Treatment, 195, 421-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yam, C., Esteva, F.J., Patel, M.M., Raghavendra, A.S., Ueno, N.T., Moulder, S.L., et al. (2019) Efficacy and Safety of the Combination of Metformin, Everolimus and Exemestane in Overweight and Obese Postmenopausal Patients with Metastatic, Hormone Receptor-Positive, Her2-Negative Breast Cancer: A Phase II Study. Investigational New Drugs, 37, 345-351. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Bashraheel, S.S., Kheraldine, H., Khalaf, S. and Moustafa, A.A. (2023) Metformin and Her2-Positive Breast Cancer: Mechanisms and Therapeutic Implications. Biomedicine & Pharmacotherapy, 162, Article ID: 114676. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Corleto, K.A., Strandmo, J.L. and Giles, E.D. (2024) Metformin and Breast Cancer: Current Findings and Future Perspectives from Preclinical and Clinical Studies. Pharmaceuticals, 17, Article No. 396. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Jafari, L. and Akhter, N. (2021) Heart Failure Prevention and Monitoring Strategies in Her2-Positive Breast Cancer: A Narrative Review. Breast Cancer Research and Treatment, 186, 295-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
De Francesco, E.M., Cirillo, F., Vella, V., Belfiore, A., Maggiolini, M. and Lappano, R. (2022) Triple-Negative Breast Cancer Drug Resistance, Durable Efficacy, and Cure: How Advanced Biological Insights and Emerging Drug Modalities Could Transform Progress. Expert Opinion on Therapeutic Targets, 26, 513-535. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Basu, A., Upadhyay, P., Ghosh, A., Bose, A., Gupta, P., Chattopadhyay, S., et al. (2021) Hyaluronic Acid Engrafted Metformin Loaded Graphene Oxide Nanoparticle as CD44 Targeted Anti-Cancer Therapy for Triple Negative Breast Cancer. Biochimica et Biophysica Acta (BBA)—General Subjects, 1865, Article ID: 129841. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Repas, J., Zupin, M., Vodlan, M., Veranič, P., Gole, B., Potočnik, U., et al. (2022) Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells. Cancers, 14, Article No. 1343. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Shi, B., Hu, X., He, H. and Fang, W. (2021) Metformin Suppresses Breast Cancer Growth via Inhibition of Cyclooxygenase-2. Oncology Letters, 22, Article No. 615. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Lee, J.O., Kang, M.J., Byun, W.S., Kim, S.A., Seo, I.H., Han, J.A., et al. (2019) Metformin Overcomes Resistance to Cisplatin in Triple-Negative Breast Cancer (TNBC) Cells by Targeting RAD51. Breast Cancer Research, 21, Article No. 115. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Basheer, H.A., Alhusban, M.A., Zaid Alkilani, A., Alshishani, A., Elsalem, L. and Afarinkia, K. (2023) Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment. Cancers, 15, Article No. 5004. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Barakat, H.E., Hussein, R.R.S., Elberry, A.A., Zaki, M.A. and Ramadan, M.E. (2022) The Impact of Metformin Use on the Outcomes of Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: An Open-Labelled Randomized Controlled Trial. Scientific Reports, 12, Article No. 7656. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Yu, J.M., Hsieh, M.C., Qin, L., et al. (2019) Metformin Reduces Radiation-Induced Cardiac Toxicity Risk in Patients Having Breast Cancer. American Journal of Cancer Research, 9, 1017-1026.
|
|
[32]
|
Serageldin, M.A., Kassem, A.B., El-Kerm, Y., Helmy, M.W., El-Mas, M.M. and El-Bassiouny, N.A. (2023) The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-Diabetic Breast Cancer Patients: A Randomised Controlled Study. Drug Safety, 46, 587-599. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Goodwin, P.J., Chen, B.E., Gelmon, K.A., Whelan, T.J., Ennis, M., Lemieux, J., et al. (2023) Effect of Metformin versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer. Journal of Clinical Oncology, 41, 5356-5362. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Essa, N.M., Salem, H.F., Elgendy, M.O., Gabr, A., Omran, M.M., Hassan, N.A., et al. (2022) Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment. Journal of Clinical Medicine, 11, Article No. 5505. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Wu, Z., Qu, B., Huang, X., Song, Y., Gao, P., Shi, J., et al. (2020) The Potential Adjunctive Benefit of Adding Metformin to Standard Treatment in Inoperable Cancer Patients: A Meta-Analysis of Randomized Controlled Trials. Annals of Translational Medicine, 8, 1404-1404. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Pei, X., Wang, X., Xian, J., Mi, J., Gao, J., Li, X., et al. (2020) Metformin and Oxyphotodynamic Therapy as a Novel Treatment Approach for Triple-Negative Breast Cancer. Annals of Translational Medicine, 8, Article No. 1138. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Sahu, P., Camarillo, I.G. and Sundararajan, R. (2024) Efficacy of Metformin and Electrical Pulses in Breast Cancer MDA-MB-231 Cells. Exploration of Targeted Anti-tumor Therapy, 5, 54-73. [Google Scholar] [CrossRef] [PubMed]
|